Emanuela Messa

Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

Emanuela Messa, Sonia Carturan, Chiara Maffè et al. · Haematologica · 2010 · 131 citations · Full text

Medicine, Hematology, Pharmacology +17

The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance

Daniela Cilloni, F. Messa, Francesca Arruga et al. · Leukemia · 2005 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

Michele Baccarani, Giovanni Martinelli, Gianantonio Rosti et al. · Blood · 2004 · 106 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis

Emanuela Messa, Daniela Cilloni, F. Messa et al. · Acta Haematologica · 2008 · 104 citations

Medicine, Hematology, Pharmacology +17

Increase in platelet count in older, poor‐risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all‐trans retinoic acid

Chiara Pilatrino, Daniela Cilloni, Emanuela Messa et al. · Cancer · 2005 · 100 citations · Full text

Medicine, Hematology, Pharmacology +16